News
MRFF backs UQ epilepsy research
UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.
Led by Professor Ernst Wolvetang, the project aims to prove the safety and efficacy of venom-based drugs by testing them on lab-grown brain and heart organoids grown from the cells of epilepsy patients.
The research aims to pave the way for human clinical trials and to establish organoids as a tool that can be used to test experimental treatments and therapies.
The funding has been provided through the MRFF’s Stem Cell Therapies grant scheme.
Media contactUQ Communications
communications@uq.edu.au
+61 429 056 139
Related articles
UQ leading project to improve dental health in aged care
A large-scale project to deliver urgently needed oral health care to aged care residents in regional Queensland and New South Wales is being led by researchers at The University of Queensland.
13 May 2026
Analysis
Hantavirus is very different to COVID. Here’s why the ‘Andes virus’ won’t cause the next pandemic
For many people, news of a virus outbreak on a cruise ship immediately brings back memories of COVID. However, the comparison only goes so far.
12 May 2026